期刊
CURRENT OPINION IN PHARMACOLOGY
卷 12, 期 6, 页码 683-689出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.coph.2012.09.007
关键词
-
资金
- Ludwig Institute for Cancer Research
- Institut National de la Sante et de la Recherche Medicale
- University of Toulouse III
- Institut Claudius Regaud
- Fondation de France
- Institut National du Cancer
- Conseil Regional de Midi-Pyrenees
The oncoprotein MUC-1 was shown to upregulate the transcription of genes encoding cholesterol and lipid metabolic enzymes and correlated with a resistance to Tamoxifen (Tam) despite the presence of estrogen receptor a in breast cancer tumors. The importance of this observation is supported by molecular studies on Tam suggesting two additional pharmacological targets involved in cholesterol metabolism. These observations demonstrate the potential importance of cholesterol and lipid metabolism in the pharmacology/therapeutic effects of Tam.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据